Nurix Therapeutics, NRIX
We recently published a list of 10 Worst ARK Stocks To Buy According to Short Sellers. In this article, we are going to take ...
H.C. Wainwright analyst Robert Burns raised the firm’s price target on Nurix Therapeutics (NRIX) to $35 from $30 and keeps a Buy rating on the ...
During the last three months, 9 analysts shared their evaluations of Nurix Therapeutics NRIX, revealing diverse outlooks from ...
Massachusetts Financial Services Co. MA lowered its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 29.3% ...
In this article, we are going to take a look at where Nurix Therapeutics, Inc. (NASDAQ:NRIX) stands against the other small-cap biotech stocks. The biotechnology sector is expanding quickly due to ...
SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage ...
Short interest in Nurix Therapeutics Inc (NASDAQ:NRIX) increased during the last reporting period, rising from 9.46M to 9.60M. This put 14.55% of the company's publicly available shares short.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
SAN FRANCISCO, Nov. 17, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nurix Therapeutics (NRIX – Research Report), ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback